These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22891991)

  • 21. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylation of supercooled smectic cholesteryl myristate nanoparticles.
    Mengersen F; Bunjes H
    Eur J Pharm Biopharm; 2012 Jun; 81(2):409-17. PubMed ID: 22487056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of phospholipid-stabilized submicron aqueous dispersions of coenzyme Q₁₀ presenting continuous vibrating-mesh nebulization performance.
    Carvalho TC; McCook JP; Narain NR; McConville JT
    J Liposome Res; 2013 Dec; 23(4):276-90. PubMed ID: 23772691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion.
    Shi S; Chen H; Cui Y; Tang X
    Int J Pharm; 2009 May; 373(1-2):147-55. PubMed ID: 19429300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
    Bunjes H; Koch MH
    J Control Release; 2005 Oct; 107(2):229-43. PubMed ID: 16023752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats.
    Lu Y; Zhang Y; Yang Z; Tang X
    Int J Pharm; 2009 Jan; 366(1-2):160-9. PubMed ID: 18835427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine.
    Qi C; Chen Y; Huang JH; Jin QZ; Wang XG
    J Sci Food Agric; 2012 Mar; 92(4):787-93. PubMed ID: 22101976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
    Yang Y; Feng JF; Zhang H; Luo JY
    Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of colloidal silver nanoparticles trapped in lipid bilayer: effect of lecithin concentration and applied temperature.
    Barani H; Montazer M; Braun HG; Dutschk V
    IET Nanobiotechnol; 2014 Dec; 8(4):282-9. PubMed ID: 25429509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
    Heiati H; Tawashi R; Phillips NC
    J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation of a stable and high-loaded quercetin injectable emulsion.
    Sun H; Xu H; Yang X; Li N; Liu Z; Pan W; Yuan Y
    Pharm Dev Technol; 2011; 16(6):609-15. PubMed ID: 20718691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral formulation of larotaxel lipid microsphere tackling poor solubility and chemical instability.
    Teng F; Yang H; Li G; Lin X; Zhang Y; Tang X
    Int J Pharm; 2014 Jan; 460(1-2):212-9. PubMed ID: 24184034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers.
    Kuntsche J; Koch MH; Drechsler M; Bunjes H
    Colloids Surf B Biointerfaces; 2005 Jul; 44(1):25-35. PubMed ID: 15990283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A biologically friendly single step method for gold nanoparticle formation.
    Sharma D
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):330-7. PubMed ID: 21459561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparation of tanshinone transfersome and its deformability].
    Hu YJ; Zhang ZY; Li HL; Zhang SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):297-300. PubMed ID: 16546731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.